Arcturus Therapeutics Ltd. Analysis
| Analyst Ratings |
|
Average Target Price
|
42.05
|
|
Average Rating
|
3.50
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
2
|
|
# Sells
|
2
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.81
|
-1.33
|
0.48
|
26.52%
|
|
2022-06-30
|
-1.90
|
-0.82
|
1.08
|
56.84%
|
|
2022-03-31
|
-1.44
|
-1.94
|
-0.50
|
-34.72%
|
|
2021-12-31
|
-1.72
|
-1.47
|
0.25
|
14.53%
|
|
2021-09-30
|
-1.59
|
-2.05
|
-0.46
|
-28.93%
|
|
2021-06-30
|
-2.15
|
-2.07
|
0.08
|
3.72%
|
|
2021-03-31
|
-1.25
|
-2.15
|
-0.90
|
-72.00%
|
|
2020-12-31
|
-0.88
|
-1.25
|
-0.37
|
-42.05%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-4.09
|
|
2021-12-31
|
-7.74
|
|
2020-12-31
|
-3.39
|
|
2019-12-31
|
-2.07
|
|
2018-12-31
|
-2.57
|
|
2017-12-31
|
-3.60
|
|
2016-12-31
|
-6.23
|
|
2015-12-31
|
-2.10
|
|
2014-12-31
|
-5.55
|
|
2013-12-31
|
-5.53
|